Target intelligence / Profile preview

RNA, U6 small nuclear 699, pseudogene (RNU6-699P)

Target
RNU6-699P
Molecular classification
Pseudogene, Non-coding RNA, Small nuclear RNA pseudogene, U6 small nuclear RNA pseudogene
01

Overview

RNU6-699P is classified as a pseudogene of the U6 small nuclear RNA family[6][5]. U6 small nuclear RNAs (snRNAs) are integral parts of the spliceosome, the molecular complex responsible for the splicing of pre-messenger RNA in eukaryotic cells[1][3]. However, a pseudogene is a genomic DNA sequence similar to a gene but typically non-functional; it may arise from gene duplication or retrotransposition and does not produce functional RNA or protein products[5][4].\n\nRNU6-699P itself is not believed to be functional as it is a processed pseudogene[6][5]. The genuine U6 snRNAs play a central and catalytic role in spliceosome assembly and mRNA processing[1][3], but the vast majority of U6-like sequences in the human genome, including RNU6-699P, are presumed to be remnants of evolutionary duplication events and are unexpressed or non-functional[4][6]. There is no evidence that RNU6-699P acts as a therapeutic target, is implicated as a biomarker, interacts with any drugs, or is associated with human disease roles[6][5][4]. It is mostly relevant as part of genomic and evolutionary studies to understand the frequency and structure of pseudogenes originating from functionally essential snRNAs[5][1][4].

Other names
RNU6-699P

Beyond the preview

Go deeper on RNA, U6 small nuclear 699, pseudogene (RNU6-699P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 699, pseudogene (RNU6-699P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call